Toll-Like Receptors and COVID-19: A Two-Faced Story with an Exciting Ending

Livia Onofrio1 Department of Clinical Medicine & Surgery, University of Naples “Federico II”, Naples, Italy

Michele Caraglia2 Department of Precision Medicine, University of Campania “L. Vanvitelli”, Naples, Italy

Gaetano Facchini3 Medical Oncology, ASL Napoli 2 Nord, “S.M. delle Grazie Hospital”, Pozzuoli (NA), Italy

Vincenzo Margherita1 Department of Clinical Medicine & Surgery, University of Naples “Federico II”, Naples, Italy

Sabino De Placido1 Department of Clinical Medicine & Surgery, University of Naples “Federico II”, Naples, Italy

Carlo Buonerba4 Regional Reference Center for Rare Tumors, Department of Oncology & Hematology, AOU Federico II of Naples, Naples, Italy;5 National Reference Center for Environmental Health, Zoo-prophylactic Institute of Southern Italy, Portici, ItalyCorrespondence[email protected]

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Toll-Like Receptors and COVID-19: A Two-Faced Story with an Exciting Ending

Information for

Open access

Opportunities

Help and information

Toll-Like Receptors and COVID-19: A Two-Faced Story with an Exciting Ending

Financial & competing interests disclosure

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature